Channel Therapeutics Statistics

Total Valuation

CHRO has a market cap or net worth of $8.84 million. The enterprise value is $11.28 million.

Market Cap	8.84M
Enterprise Value	11.28M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CHRO has 6.60 million shares outstanding. The number of shares has increased by 173.25% in one year.

Current Share Class	6.60M
Shares Outstanding	6.60M
Shares Change (YoY)	+173.25%
Shares Change (QoQ)	+1.51%
Owned by Insiders (%)	8.36%
Owned by Institutions (%)	2.95%
Float	2.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.18

Current Ratio	0.18
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25.62

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-188.95%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	178.07%
Revenue Per Employee	n/a
Profits Per Employee	-$669,147
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.52%
50-Day Moving Average	1.20
200-Day Moving Average	1.14
Relative Strength Index (RSI)	65.75
Average Volume (20 Days)	54,789

Short Selling Information

The latest short interest is 125,880, so 1.91% of the outstanding shares have been sold short.

Short Interest	125,880
Short Previous Month	156,357
Short % of Shares Out	1.91%
Short % of Float	4.91%
Short Ratio (days to cover)	1.54

Income Statement

Revenue	n/a
Gross Profit	272,308
Operating Income	-7.47M
Pretax Income	-8.98M
Net Income	-7.36M
EBITDA	n/a
EBIT	-7.47M
Earnings Per Share (EPS)	-$1.24

Full Income Statement

Balance Sheet

The company has $131,317 in cash and $2.50 million in debt, giving a net cash position of -$2.37 million or -$0.36 per share.

Cash & Cash Equivalents	131,317
Total Debt	2.50M
Net Cash	-2.37M
Net Cash Per Share	-$0.36
Equity (Book Value)	-4.20M
Book Value Per Share	-0.68
Working Capital	-4.20M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.43M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CHRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-173.25%
Shareholder Yield	-173.25%
Earnings Yield	-82.66%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-6.92%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1